VENLAFAXINE-INDUCED DEPRESSION OF WIND-UP ACTIVITY IN MONONEUROPATHIC RATS IS POTENTIATED BY INHIBITION OF BRAIN 5-HT1A RECEPTOR EXPRESSION IN VIVO

References

• Arborelius, L., Nomikos, G. G., Grillner, P., Fiertel, P., Hook, B. B., Hacksell, U., & Svensson, T. H. (1995). 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Naunyn Schiniedeberg’s Archives of Pharmacology, 352(2), 157–165.
   PubMedGoogle Scholar
• Ardid, D., Alloul, A., Brousse, G., Jourdan, D., Picard, P., Dubray, C., & Eschalier, A. (2001). Potentiation of the antinociceptive effect of clomipramine by a 5-HT1A antago- nist in neuropathic pain in rats. British Journal of Pharmacology, 132(5), 1118–1126.
   PubMedGoogle Scholar
• Artigas, F., Romero, L., de Montigny, C., & Buer, P. (1996). Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends in Neurosciences, 19(9), 378–383.
   PubMed Web of Science ®Google Scholar
• Beique, J. C., de Montigny, C., Buer, P., & Debonnel, G. (1999). Venlafaxine: Discrep- ancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Synapse, 32(3), 198–211.
   PubMedGoogle Scholar
• Bennett, G. J., & Xie, Y. K. (1988). A peripheral mononeuropathy in rat that produce disorders of pain sensation like those seen in man. Pain, 33(1), 87–107.
   PubMed Web of Science ®Google Scholar
• Bhargava, V. K., & Saha, L. (2001). Serotonergic mechanism in imipramine induced antinoci- ception in rat tail flick test. Indian Journal of Physiology and Pharmacology, 45(1), 107–110.
   PubMedGoogle Scholar
• Blier, P. (2001). Pharmacology of rapid-onset antidepressant treatment strategies. Journal of Clinical Psychiatiy, 62(Suppl. 15), 12–17.
   Google Scholar
• Chapman, V., & Dickenson, A. H. (1993). The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord. Neuroscience Letters, 157(2), 149–152.
   PubMedGoogle Scholar
• Corradetti, R., Laaris, N., Hanoun, N., Laporte, A. M., Le Poul, E., Hamon, M., & Lanfumey, L. (1998). Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain. British Journal of Pharmacology, 123(3), 449–462.
   PubMed Web of Science ®Google Scholar
• Corradetti, R., Le Poul, E, Laaris, N., Hamon, M., & Lanfumey, L. (1996). Electrophysi- ological effects of N-(2-(4-(2-inethoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cy- clohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA 1 hippocampal pyramidal cells in vitro. Journal of Pharmacology and Experimental Therapeutics, 278(2), 679–688.
   PubMedGoogle Scholar
• Cryan, J. F., Kelliher, P., Kelly, J. P., & Leonard, B. E. (1999). Comparative effects of serotonergic agonists with varying efficacy at the 5-HT1A receptor on core body tem- perature: Modification by the selective 5-HT1A receptor antagonist WAY 100635. Journal of Psychopharmacology, 13(3), 278–283.
   PubMedGoogle Scholar
• Dickenson, A. H., & Sullivan, A. F. (1987). Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones fol- lowing C fibre stimulation. Neuropharmacology, 26(8), 1235–1238.
   PubMed Web of Science ®Google Scholar
• Duale, C., Raboisson, P., Molat, J. L., & Dallel, R. (2001). Systemic morphine reduces the wind-up of trigeminal nociceptive neurons. Neuroreport, 12(10), 2091–2096.
   PubMedGoogle Scholar
• Eide, P. K. (2000). Wind-up and the NMDA receptor complex from a clinical perspective. European Journal of Pain, 4(1), 5–15.
   PubMedGoogle Scholar
• Fornal, C. A., Litto, W. J., Metzler, C. W., Marrosu, F., Tada, K., & Jacobs, B. L. (1994). Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and an- tagonist drug administration in behaving cats. Journal of Pharmacology and Experi- mental Therapeutics, 270(3), 1345–1358.
   Google Scholar
• Gartside, S. E., Umbers, V., Hajos, M., & Sharp, T. (1995). Interaction between a selec- tive 5-HT1A receptor antagonist and an SSRI in vivo: Effects on 5-HT cell firing and extracellular 5-HT. British Journal of Pharmacology, 115(6), 1064–1070.
   PubMedGoogle Scholar
• Gjerstad, J., Tjolsen, A., & Hole, K. (1996). The effect of 5-HT1A receptor stimulation on nociceptive dorsal horn neurones in rats. European Journal of Pharmacology, 318(2- 3), 315–321.
   Google Scholar
• Howell, S. R., Hicks, D. R., Scatina, J. A., & Sisenwine, S. F. (1994). Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals. Xenobiotica, 24(4), 315–327.
   PubMed Web of Science ®Google Scholar
• Laurido, C., Pelissier, T., Perez, H., Flores, F., & Hernandez, A. (2001). Effect of ketamine on spinal cord nociceptive transmission in normal and monoarthritic rats. Neuroreport, 12(8), 1551–1554.
   PubMedGoogle Scholar
• Millan, M. J., Rivet, J. M., Canton, H., Le Marouille-Girardon, S., & Gobert, A. (1993). Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated ac- tivity in the rat: A pharmacological characterization of the actions of novel agonists and antagonists. Journal of Pharmacology and Experimental Therapeutics, 264(3), 1364- 1376.
   Google Scholar
• Millan, M. J. (2002). Descending control of pain. Progress in Neurobiology, 66(6), 355–474.
   PubMed Web of Science ®Google Scholar
• Patel, S., Naeem, S., Kesingland, A., Froestl, W., Capogna, M., Urban, L., & Fox, A. (2001). The effects of GABAB agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain, 90(3), 217–226.
   PubMed Web of Science ®Google Scholar
• Peltegrino, L. J., & Cushman, A. J. (1967). A stereotaxic atlas of the rat brain. New York: Appleton-Century-Crofts.
   Google Scholar
• Reeve, A. J., & Dickenson, A. H. (1995). The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat. British Journal of Pharmacology, 116(4), 2221–2228.
   PubMedGoogle Scholar
• Sari, Y., Sibella, C., Verge, D., Hamon, M., & Miquel, M. C. (1999). Limited inhibition of 5-HT1A receptor expression in the rat brain by antisense RNA and oligodesoxynucleotides. Neuroscience Letters, 259(3), 191–195.
   PubMedGoogle Scholar
• Sierralta, F., Pinardi, G., & Miranda, H. F. (1995). Effect of p-chlorophenylalanine and alpha-methyltyrosine on the antinociceptive effect of antidepressant drugs. Pharmacol- ogy and Toxicology, 77(4), 276–280.
   PubMedGoogle Scholar
• Sindrup, S. H., & Jensen, T. S. (1999). Efficacy of pharmacological treatments of neuro- pathic pain: An update and effect related to mechanism of drug action. Pain, 83(3), 389–400.
   PubMed Web of Science ®Google Scholar
• Sullivan, A. F., Kalso, E. A., McQuay, H. J., & Dickenson, A. H. (1992). The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat. European Journal of Pharmacology, 215(1), 127–133.
   PubMedGoogle Scholar
• Testa, R., Guarneri, L., Poggesi, E., Angelico, P., Velasco, C., Ibba, M., Cilia, A., Motta, U., Riva, C., & Leonardi, A. (1999). Effect of several 5-hydroxytryptamine1A receptor ligands on the micturition reflex in rats: Comparison with WAY 100635. Journal of Pharmacology and Experimental Therapeutics, 290(3), 1258–1269.
   PubMedGoogle Scholar
• The Committee for Research and Ethical Issues of the International Association for the Study of Pain. (1980). Ethical standards for investigations of experimental pain in animals. Pain, 9(2), 141–143.
   PubMedGoogle Scholar
• Valverde, O., Mico, J. A., Maldonado, R., Mellado, M., & Gibert-Rahola, J. (1994). Par- ticipation of opioid and monoaminergic mechanisms on the antinociceptive effect in- duced by tricyclic antidepressants in two behavioural pain tests in mice. Progress in Neuropsychopharmacology and Biological Psychiatry, 18(6), 1073–1092.
   PubMedGoogle Scholar